Mounjaro vs Wegovy: Key Differences For UK Buyers
What Is 5mg Mounjaro to Wegovy: Understanding the Conversion
When comparing what is 5mg Mounjaro to Wegovy, it's important to understand that these are fundamentally different medications with distinct mechanisms. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, whilst Wegovy (semaglutide) works solely through GLP-1 receptor activation. The 5mg Mounjaro dose represents a mid-range therapeutic level in its escalation schedule, whereas Wegovy's maximum licensed dose is 2.4mg weekly. Both prescription-only medicines require clinical assessment and prescriber oversight, but their different mechanisms mean direct dose comparisons aren't clinically meaningful. EverydayMeds provides access to genuine Wegovy through our GPhC-registered pharmacy (#9012878), ensuring you receive authentic treatment with proper clinical supervision.
The choice between treatments depends on individual clinical factors rather than simple dose equivalence. Wegovy's established clinical evidence through the STEP trial programme demonstrates its effectiveness when used alongside a reduced-calorie diet and increased physical activity. Mounjaro's dual mechanism offers a different approach to appetite regulation and glucose metabolism. Your prescriber will consider your medical history, current medications, and treatment goals when determining the most appropriate option. Both treatments are available through EverydayMeds, with comprehensive support from initial assessment through ongoing treatment management.
UK Online Pricing: Wegovy Costs and Bundle Options
Understanding what is 5mg Mounjaro to Wegovy includes comparing UK pricing structures for informed decision-making. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers benefit from discount code FIRST40 applied at checkout, whilst returning customers use DOSE25 for continued savings. Our bundle options provide convenient multi-month supplies, such as the Intro Duo (0.25mg & 0.5mg) at £169.99, ensuring seamless treatment progression. These final prices include clinical assessment, prescriber review, and temperature-controlled delivery to your UK address.
Bundle pricing reflects the convenience of Reliable Supply and reduced ordering frequency rather than simple cost savings. The Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99, providing three months of stepped dose increases with single delivery convenience. For maintenance patients, the Ultimate Stability Trio offers three 2.4mg pens at £649.99, ensuring consistent supply for quarterly treatment periods. All pricing includes comprehensive clinical support, with express prescriber review available within 24 hours for urgent treatment needs. This transparent pricing structure helps patients plan their weight management investment with confidence in authentic, clinically-supervised treatment.
Clinical Evidence: What Is 5mg Mounjaro to Wegovy in Trial Results
When evaluating what is 5mg Mounjaro to Wegovy through clinical evidence, both treatments demonstrate efficacy in their respective trial programmes. The STEP trials, particularly Wilding et al., NEJM, 2021, showed that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo. The STEP 2 trial demonstrated around clinically studied weight loss in patients with type 2 diabetes, whilst STEP 3 showed approximately 16% reduction with intensive behavioural therapy. These results represent average outcomes in controlled trial conditions and individual results may vary.
Mounjaro's SURMOUNT trials demonstrate its dual GIP/GLP-1 mechanism's potential, though direct comparison with Wegovy trials isn't appropriate due to different study designs and populations. The SELECT cardiovascular outcomes trial showed Wegovy reduced major cardiovascular events by 20% (HR 0.80) in adults with established cardiovascular disease. Both treatments require ongoing use, as STEP 1 extension data indicated patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising that weight management represents a long-term health commitment.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding what is 5mg Mounjaro to Wegovy requires grasping their different mechanisms of action within the body's appetite regulation systems. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone glucagon-like peptide-1, which is released after eating to signal satiety. This medication works primarily in the brain's appetite centres, specifically the hypothalamus, to reduce hunger signals and promote feelings of fullness after smaller meals. The GLP-1 mechanism also slows gastric emptying, meaning food remains in the stomach longer, contributing to sustained satiety between meals. Additionally, Wegovy may help reduce food cravings, particularly for high-calorie foods, supporting adherence to reduced-calorie dietary plans. This single-pathway approach provides targeted appetite regulation whilst maintaining the body's natural metabolic processes when used alongside lifestyle modifications.
EverydayMeds Ordering Process: Assessment to Delivery
Accessing Wegovy through EverydayMeds involves a streamlined three-step process designed for UK patients seeking what is 5mg Mounjaro to Wegovy information and treatment access. The journey begins with our comprehensive three-minute online clinical assessment, covering medical history, current medications, weight management goals, and any contraindications to semaglutide therapy. Following submission, our qualified prescribers review your assessment within standard three working days, or within 24 hours through our express service for urgent clinical needs. Once approved, your genuine Novo Nordisk Wegovy is dispatched via next-day delivery using specialised cold-chain packaging to maintain the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures all medications meet strict UK pharmaceutical standards, with tracking information provided for complete transparency. This efficient process eliminates traditional pharmacy queues whilst maintaining rigorous clinical oversight and patient safety standards.
Storage and Practical Considerations for UK Patients
When comparing what is 5mg Mounjaro to Wegovy, storage requirements represent a practical advantage for Wegovy users in the UK climate. Wegovy pens must be stored in the fridge at 2-8°C before first use, but once removed, they remain stable at room temperature below 30°C for up to six weeks, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more suitable for travel, business trips, or situations where refrigeration access is temporary unavailable. The FlexTouch pen design provides precise dose delivery with clear dosing windows and automatic needle safety features, whilst the mandatory dose escalation schedule (0.25mg to 2.4mg over 16 weeks) allows gradual tolerance development and side effect minimisation. Each pen contains four weekly doses, with disposal through household sharps containers or local pharmacy return schemes. The MHRA's additional monitoring status (Black Triangle ▼) ensures continued safety surveillance as part of the UK's robust pharmacovigilance system.
Dose Escalation: What Is 5mg Mounjaro to Wegovy Treatment Journey
Understanding what is 5mg Mounjaro to Wegovy includes recognising their different dose escalation pathways and treatment progressions. Wegovy follows a mandatory 16-week escalation schedule starting at 0.25mg weekly for the first four weeks, progressing through 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), before reaching the 2.4mg maintenance dose from week 17 onwards. This graduated approach minimises gastrointestinal side effects whilst allowing the body to adapt to increasing semaglutide levels. Mounjaro's escalation reaches higher absolute doses including the 5mg level, but this doesn't indicate greater potency due to the different receptor mechanisms involved. Both treatments require consistent weekly administration on the same day each week, with flexibility for day changes when necessary under clinical guidance.
The newly MHRA-approved 7.2mg Wegovy dose (January 2026) provides future escalation options for patients requiring additional support beyond 2.4mg, though this higher strength isn't yet available through EverydayMeds pending supply arrangements. Dose escalation cannot be rushed or skipped, as this increases the risk of gastrointestinal intolerance including nausea, vomiting, and diarrhoea. Our clinical team monitors patient progress throughout the escalation phase, with dose hold or reduction protocols available for patients experiencing persistent side effects. This personalised approach ensures optimal treatment outcomes whilst maintaining safety standards throughout the weight management journey.
Why Choose EverydayMeds for Your Weight Management Treatment
Selecting EverydayMeds for what is 5mg Mounjaro to Wegovy treatment access provides distinct advantages for UK patients seeking reliable prescription-only medicine supply. Our GPhC-registered pharmacy status (#9012878) ensures authentic Novo Nordisk Wegovy sourced directly from licensed UK wholesalers, eliminating concerns about counterfeit or grey-market products. The combination of clinical expertise, competitive pricing with transparent discount codes (FIRST40 for new customers, DOSE25 for returning patients), and next-day delivery creates a comprehensive service model designed for modern healthcare needs. Our prescribers maintain ongoing clinical relationships with patients, providing dose adjustment guidance, side effect management, and treatment optimisation support throughout the weight management journey.
The convenience of online access doesn't compromise clinical standards, with thorough assessment protocols ensuring appropriate patient selection and ongoing safety monitoring. Bundle options like our Intro Trio (0.25mg, 0.5mg & 1mg) at £299.99 provide seamless dose progression without repeated ordering, whilst our express prescriber review service accommodates urgent clinical needs within 24 hours. This integrated approach combines pharmaceutical excellence with patient convenience, making professional weight management support accessible to UK patients seeking alternatives to traditional clinic-based treatment models. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which treatment best aligns with your individual clinical profile and lifestyle requirements.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
